Overcoming this will require the utilization of alternative diagnostics, such as targeted imaging (e.g., 18F-fluoroestradiol PET, magnetic resonance spectroscopy (MRS) to detect LDHA activity), and the detection of circulating tumor DNA (ctDNA). This evidence concerns the gene LDHA and neoplasm.